Statistical properties and use of sequential methods in randomized clinical trials when the response criterion is censored.
Bénichou
J
J
Départment de Biostatistique et Informatique Médicale, Hôpital Saint-Louis, Paris, France.
Chastang
C
C
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data*; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy; D008175:Lung Neoplasms / Q000628:therapy; D009369:Neoplasms / Q000401:mortality / Q000628:therapy*; D011241:Prednisone / Q000008:administration & dosage; D011897:Random Allocation; D012107:Research Design; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone